top of page


Outstanding achievement award

Fulvio Mavilio

Fulvio Mavilio is Professor of Molecular Biology at the University of Modena and Reggio Emilia, Modena, Italy, and, from January 2022, Chief Scientific Officer of Orchard Therapeutics, London. Previously, he was CSO of Smart Immune, Paris; Vice President, Translational Science at Audentes Therapeutics, San Francisco (2017-2021); Adjunct Professor of Genetics at the Paris Descartes University, Paris (2017); Scientific Director of Genethon, Evry, (2011-2017); co-Director of the Center for Regenerative Medicine at the University of Modena, (2008-2011); Director of Discovery at Molmed SpA (2002-2005), and co-Director of the San Raffaele-Telethon Institute of Gene Therapy in Milan, Italy (1994-1999). He obtained a Ph.D. in Medical Genetics at the University of Rome in 1979, and trained at the Wistar Institute in Philadelphia, PA (1986-1988). An expert and a pioneer in the fields of gene therapy and stem cell research, Dr. Mavilio has published over 200 articles in major international journals. He is a member of the European Molecular Biology Organization and past member of the Boards of the American and European Societies of Gene and Cell Therapy.

Supported by:

Young Investigator Awards

Julian Grunewald

Julian Grünewald is a physician-scientist, Emmy Noether group leader, and Assistant Professor of Gene Editing at the Technical University of Munich (TUM). His lab is focused on engineering new CRISPR technologies for research and therapeutic applications in cardiovascular medicine. After medical school and training as a resident of internal medicine, Julian trained as a postdoc in the laboratory of J. Keith Joung at Massachusetts General Hospital and Harvard Medical School.

Maria Ester Bernardo

Dr Bernardo is Responsible for the Pediatric Transplant Unit and Pediatric Allogeneic Transplant Coordinator of the Pediatric Immunohematology Unit, San Raffaele Scientific Institute. At SR-TIGET, she is Group Leader and Clinical Coordinator of the Pediatric Clinical Research Unit. She is Associate Professor of Pediatrics at Vita-Salute San Raffaele University Medical School, Milan.

She is PI of the Phase I/II clinical trial of ex-vivo gene therapy for the treatment of patients affected by Hurler Syndrome. She is Co-author of >100 peer-reviewed articles published in international journals; H index (Scopus) = 42.


bottom of page